PKS Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Buy
990
+284
+40% +$290K 0.19% 112
2026
Q1
$648K Buy
706
+58
+9% +$58.8K 0.15% 139
2025
Q4
$697K Sell
648
-116
-15% -$111K 0.16% 128
2025
Q3
$583K Sell
764
-168
-18% -$125K 0.12% 142
2025
Q2
$726K Buy
932
+326
+54% +$253K 0.18% 111
2025
Q1
$498K Sell
606
-16
-3% -$13.3K 0.14% 134
2024
Q4
$481K Buy
+622
New +$515K 0.12% 146

Other funds holding LLY

PKS Advisory Services's LLY Position: Q2 2026 in Review

PKS Advisory Services increased its Eli Lilly (LLY) stake by 40% in Q2 2026, buying an estimated $290K and bringing the position to 990 shares worth $1.19M. The position accounts for 0.19% of the portfolio, ranked #112.

PKS Advisory Services first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • PKS Advisory Services held 990 shares of Eli Lilly worth $1.19M as of Q2 2026.
  • PKS Advisory Services bought 284 Eli Lilly shares in Q2 2026, an estimated $290K.
  • Eli Lilly made up 0.19% of PKS Advisory Services's portfolio in Q2 2026, its #112 holding.
  • PKS Advisory Services first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on PKS Advisory Services's 13F filing for Q2 2026, filed 4 Aug 2026.